Pritesh Shah, Chief Commercial Officer at NovoCure Ltd (NVCR), sold 23,540 shares at $215.00 ($5.1M) on 2021-06-10, disclosed to the SEC on 2021-06-11.
Open-market sale of $5.1M NVCR by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2023-03-07 | $3.3M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $141K | — | Filing → |
| NVCR | SELL | 2023-03-02 | $294K | — | Filing → |